Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Okosun

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
BMC Cancer|September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphomaJulia Wendler, Christopher P Fox, Elke Valk, et al.
International Journal of Molecular Sciences|November 25, 2020
Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular LymphomaErika Larrea, Marta Fernandez-Mercado, José Afonso Guerra-Assunção, et al.
The Oncologist|July 27, 2019
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet NeedsMatthew J Matasar, Stefano Luminari, Paul M Barr, et al.
BMC Cancer|March 26, 2024
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trialGraham McIlroy, Siân Lax, Charlotte Gaskell, et al.
Ejhaem|December 24, 2025
TRBC1/TRBC2 Immunophenotyping Provides Added Value During the Diagnostic Workup of T-Cell LymphomaJoseph Taylor, Tasneem Lakum, Shaun Bevan, et al.
Haematologica|May 19, 2022
Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantationToby A Eyre, Sally F Barrington, Jessica Okosun, et al.
Haematologica|April 11, 2020
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphomaShamzah Araf, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy eraSilvia Montoto, Kate Shaw, Jessica Okosun, et al.
Hemasphere|February 27, 2023
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient CareTarec Christoffer El-Galaly, Verena I Gaidzik, Mihnea-Alexandru Gaman, et al.
Blood Advances|July 10, 2026
MRD-negativity by PBMCs and ctDNA confirms deep and durable responses following epcoritamab monotherapy in R/R FLIsil Altintas, Christopher Morehouse, Elena Favaro, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
BMC Cancer|September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphomaJulia Wendler, Christopher P Fox, Elke Valk, et al.
International Journal of Molecular Sciences|November 25, 2020
Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular LymphomaErika Larrea, Marta Fernandez-Mercado, José Afonso Guerra-Assunção, et al.
The Oncologist|July 27, 2019
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet NeedsMatthew J Matasar, Stefano Luminari, Paul M Barr, et al.
BMC Cancer|March 26, 2024
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trialGraham McIlroy, Siân Lax, Charlotte Gaskell, et al.
Ejhaem|December 24, 2025
TRBC1/TRBC2 Immunophenotyping Provides Added Value During the Diagnostic Workup of T-Cell LymphomaJoseph Taylor, Tasneem Lakum, Shaun Bevan, et al.
Haematologica|May 19, 2022
Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantationToby A Eyre, Sally F Barrington, Jessica Okosun, et al.
Haematologica|April 11, 2020
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphomaShamzah Araf, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy eraSilvia Montoto, Kate Shaw, Jessica Okosun, et al.
Hemasphere|February 27, 2023
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient CareTarec Christoffer El-Galaly, Verena I Gaidzik, Mihnea-Alexandru Gaman, et al.
Blood Advances|July 10, 2026
MRD-negativity by PBMCs and ctDNA confirms deep and durable responses following epcoritamab monotherapy in R/R FLIsil Altintas, Christopher Morehouse, Elena Favaro, et al.
Pageof 7